ArticleBMC bioinformatics2025
fuseMLR: an R package for integrative prediction modeling of multi-omics data.
Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- PEARL: integrative multi-omics classification and omics feature discovery via deep graph learning.Bioinformatics (Oxford, England) · 2026Article
- Mass Spectrometry Proteomics: A Key to Faster Drug Discovery.Journal of medicinal chemistry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecent technological advances have enabled the simultaneous collection of multi-omics data, i.e., different types or modalities of molecular data. Integrative predictive modeling of such data is particularly challenging. Ideally, data from the different modalities are measured in the same individuals, allowing for early or intermediate integrative techniques. However, they are often not applicable when patient data only partially overlap, which requires either reducing the datasets or imputing missing values. Additionally, the diversity of data modalities may necessitate specific statistical methods rather than applying the same method across all modalities. Late integration modeling approaches analyze each data modality separately to obtain modality-specific predictions. These predictions are then aggregated into a meta-model by training a machine learning (ML) model, or by computing the weighted mean of modality-specific predictions.
resultsWe introduce the R package fuseMLR for late integration prediction modeling. The package is user-friendly, enables variable selection and the application of different ML algorithms for each modality, and automatically performs aggregation once modality-specific training is completed. We illustrate the package’s functionality in a small simulation study and with two publicly available multi-omics datasets from The Cancer Genome Atlas.
conclusionThe package fuseMLR enables predictive modeling with late integration in a systematic, structured, and reproducible way.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.